 |
|
|
| |
Virologic Response To 2-Drug ART Regimens Among
Treatment-Experienced HIV+ Patients
|
| |
| |
Reported by Jules Levin
CROI 2018 March 4-7 Boston, MA
Gerald Pierone1, Cassidy Henegar2, Jennifer Fusco2, Vani Vannappagari3, Michael Aboud4, Leigh Ragone3, Gregory Fusco2
1Whole Family Health Center, Vero Beach, FL; 2Epividian, Inc., Durham, NC; 3ViiV Healthcare, Research Triangle Park, NC; 4ViiV Healthcare, London, UK
|
| |
|
|
|
|
|
